Summary
Eli Lilly & Co. (LLY) filed a Current Report on Form 8-K on August 14, 2002, primarily to disclose the submission of sworn statements by its Chief Executive Officer and Chief Financial Officer to the SEC. This action was taken in response to a specific SEC order related to the Sarbanes-Oxley Act's precursors and accounting oversight. The sworn statements relate to the accuracy of the company's 2001 annual report on Form 10-K, its 2002 definitive proxy materials, and all subsequent quarterly (10-Q) and current (8-K) reports filed after the 2001 10-K. The statements were submitted without exceptions or modifications, indicating the company's compliance with the SEC's directive to affirm the integrity of these key financial and governance disclosures.
Key Highlights
- 1Eli Lilly & Co. (LLY) filed an 8-K on August 14, 2002.
- 2The filing pertains to sworn statements submitted by the CEO and CFO to the SEC.
- 3These statements were made in response to an SEC order regarding financial reporting accuracy.
- 4The sworn statements cover the 2001 Form 10-K, 2002 proxy materials, and subsequent 10-Q and 8-K filings.
- 5The statements were submitted without exceptions or modifications.
- 6This action reflects a heightened focus on corporate accountability and financial disclosure integrity in 2002.
- 7Charles E. Golden, EVP and CFO, signed the report on behalf of the company.